OM-Pharma

Trial Status: 
Current Trial - Enrolling

Project Summary

The modification proposes the continuation of the sequential set of studies pursuant to the Collaboration Agreement with the same scope as under the original agreement and with defined milestones as described within the modification. It also extends the project scope to develop cellular models and readouts to assess the effects of OM-85 on COVID-19 entry in human epithelial cells.

Principal Investigator: 
Research Area: 
Clinical and Population Research
Disease Type: 
COVID-19